1 / 4

Antiviral drugs Market Size, Share, Trends and Forecast (2035)

The Antiviral Drugs Market is estimated to grow at a CAGR of 6.3% during the period 2022-2035, claims Roots Analysis. Over the years, there has been a growing focus on the development of safe and effective novel antiviral drugs therapeutics owing to the rising cases of life-threatening viral diseases<br><br>For more details, visit here: https://www.rootsanalysis.com/reports/antiviral-drugs-market.html

Root2
Download Presentation

Antiviral drugs Market Size, Share, Trends and Forecast (2035)

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Antiviral drugs Market Size, Share, Trends and Forecast (2035) The Antiviral Drugs Market is estimated to grow at a CAGR of 6.3% during the period 2022-2035, claims Roots Analysis. Over the years, there has been a growing focus on the development of safe and effective novel antiviral drugs therapeutics owing to the rising cases of life-threatening viral diseases The study features an in-depth analysis, highlighting the capabilities of antiviral drug developers engaged in this domain. Amongst other elements, the report features: ● A detailed assessment of the current market landscape of commercially available antiviral drugs. ● A detailed assessment of the current market landscape of clinical-stage antiviral drugs. ● An analysis of the partnerships that have been inked by stakeholders engaged in this domain, during the period 2019-2022 (till May). ● A detailed analysis of investments that have been made into companies engaged in the antiviral drugs domain, during the period 2019-2022 (till May). ● A qualitative analysis of the five competitive forces under an insightful Porter’s Five Forces framework. ● Elaborate profiles of prominent players (shortlisted based on a proprietary criterion) engaged in development of antiviral drugs.

  2. A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below): ○ Mechanism of Action ● Fusion Inhibitors ● DNA Polymerases ● Protease Inhibitors ● Reverse Transcriptase Inhibitors ● Other Mechanisms ■ Target Indication ● Human Immunodeficiency Virus Infection ● Hepatitis ● Herpes Simplex Virus Infection ● Cytomegalovirus Infection\ ● Influenza ● Coronavirus Infection ● Other Target Indications ■ Type of Drug Target ● Virus Targets ● Host Targets

  3. ■ Type of Therapy ● Monotherapy ● Combination Therapy ○ Key Geographical Regions ● North America ● Europe ● Asia-Pacific ● Latin America ● MENA ● Rest of the World Key companies covered in the report ● AbbVie ● AstraZeneca ● Bristol-Myers Squibb ● Genentech ● Gilead Sciences ● GlaxoSmithKline (GSK) ● Johnson & Johnson ● Merck ● Novartis ● Pfizer ● Roche ● ViiV Healthcare For additional details, please visit https://www.rootsanalysis.com/reports/antiviral-drugs-market.html About Roots Analysis Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights. Contact: Ben Johnson +1 (415) 800 3415 Ben.johnson@rootsanalysis.com

More Related